| Code | 6550E | ||||||||||
| MA number | 09/0152/24-S | ||||||||||
| Product Form: | plv ino 5x40 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olikla s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.06.2024 |
| Validity: | 16.06.2029 |
| PIL: |
PIL_Pantoprazole Olikla_06_2024.pdf
|
| SPC: |
SPC_Pantoprazole Olikla_06_2024.pdf
|
| Dokument: |
VHS_SK_H_0301_001_DC_Pantoprazole Olikla PAR summary_09_2024.pdf
|
| Dokument: |
VHS_SK_H_0301_001_DC_Pantoprazole Olikla PAR_09_2024.pdf
|
| Safety feature | Yes |
| Data update: | 18.06.2024 |
